Panel Discussion: Stabilizing Development Momentum to Preserve Market Confidence During Regulatory Volatility

9:15 am - Wednesday 5th August 2026

  • Maintain investor and partner confidence by aligning regulatory pivots with disciplined communications
  • Protect timelines and budgets by responding decisively to CRLs, endpoint shifts, and evolving agency expectations
  • Strengthen resilience by leveraging patient advocacy, public affairs, and cross-functional escalation pathways during  periods of agency uncertainty

Speakers:

CLO
Fulcrum Therapeutics
Formerly Chief Legal Officer
Lexeo Therapeutics
Assistant General Counsel, Commercial Legal Lead (N. America)
BeOne Medicines
Chief Legal Officer
Disc Medicine
Chief Legal Officer
Gameto